A $2.5 million federal grant will fund a four-year study led by Kessler Foundation scientist Karen J. Nolan, PhD, to explore ...
Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable ...
Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury ...
A safe, effective alternative to invasive surgeries! The ICSCI study shows Transcutaneous Spinal Cord Stimulation helps ...
Some people with chronic, debilitating lower back pain find that it can’t be treated with surgery. And such things as ...
Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.
Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.
Suffering a spinal cord injury (SCI) in an accident is a life-altering event that comes with staggering financial ...
Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury (SCI) using spinal cord transcutaneous stimulation (scTS). This promising ...
Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.
New research shows that stimulation of the lumbosacral vertebrae region significantly elevated low blood pressure, unlike cervical or upper thoracic stimulation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback